Loading organizations...
Marley Medical has raised $9.0M across 1 funding round.
Key people at Marley Medical.
Marley Medical has raised $9.0M in total across 1 funding round.
Marley Medical operates a virtual primary care platform tailored for individuals managing common chronic diseases. The company provides a comprehensive suite of remote services, including consultations with physicians, nurses, and pharmacists, to deliver ongoing, team-based care. Its technical approach centers on proactive health management and personalized care plans designed to integrate seamlessly into patients' daily lives.
The company was co-founded in October 2021 by Chris Hogg, David Hubanks, and Joe Slavinsky. These digital health veterans previously held leadership roles at Propeller Health, a digital respiratory health company. Their collective insight stemmed from recognizing the growing need for specialized, accessible virtual care solutions for the complex and continuous management of chronic conditions, building on their experience in digital health innovation.
Marley Medical serves patients seeking dedicated support for their long-term health needs, focusing on improved outcomes through consistent engagement and tailored interventions. The company’s vision is to redefine chronic disease management by making high-quality, personalized care more accessible and integrated, empowering individuals to better control their health proactively.
Key people at Marley Medical.
Marley Medical has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Seed in October 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2021 | $9M Seed | — | Abstract Ventures, Kevin Hartz, Alchemist Accelerator, Andreessen Horowitz, Asset Management Ventures, Brainchild, Catalio Capital, CRV, DNA Capital, Energize Ventures, Jenny Fielding, Scott Hartley, Felicis Ventures, FirstHand Alliance, Flex Capital, Footwork, Forerunner Ventures, Foundry Group, Gradient Ventures, Greylock, Highbury Group, InterWest, Kapor Capital, Maniv Mobility, Maverick Capital, O'Reilly AlphaTech Ventures, Scribble Ventures, Seven Seven SIX, Storm Ventures, Techstars, Thirty Five Ventures, Thrive Capital, Toyota Ventures, Tribe Capital, TWO Sigma Ventures, Uncork Capital, Visionaire Ventures, Vzvc, Akshay Kothari, Allison Pickens (Allison Pickens Ventures), Austin Ogilvie, Chris Bennett, Daren Cotter, Dylan Field, ED Baker, Jacob Kerzner, Julia Hartz, Justin Mateen, Prescott Watson, Scott Belsky | Announced |
Marley Medical has raised $9.0M in total across 1 funding round.
Marley Medical's investors include Abstract Ventures, Kevin Hartz, Alchemist Accelerator, Andreessen Horowitz, Asset Management Ventures, Brainchild, Catalio Capital, CRV, DNA Capital, Energize Ventures, Jenny Fielding, Scott Hartley.
Marley Medical is a virtual primary care clinic specializing in managing common chronic diseases such as high blood pressure, high cholesterol, diabetes, and weight management. It serves patients who require ongoing care for chronic conditions by providing convenient, personalized care plans delivered remotely. Marley Medical offers 24/7 access to a multidisciplinary care team including physicians, nurses, and pharmacists, along with telehealth video visits, home delivery of medications, lab kits, and health monitoring devices. This approach aims to simplify chronic disease management and improve patient adherence to care plans, positioning Marley Medical as a patient-first virtual care provider with a focus on chronic care management rather than broad telehealth services[1][2][3][4].
Founded in 2021 by digital health veterans Chris Hogg, David Hubanks, and Joe Slavinsky—who previously worked at Propeller Health—Marley Medical emerged from their experience in digital health and chronic disease management. The founders aimed to create a virtual primary care company that differs from others by focusing specifically on chronic conditions and building traditional care teams rather than relying heavily on health coaches. Early traction included raising $9 million in seed funding led by notable investors such as Julie Yoo (Andreessen Horowitz) and Kristin Baker Spohn (CRV), alongside other experienced health tech founders and CEOs. The company’s management services were acquired by Starlight in October 2024, marking a significant milestone in its evolution[1][4].
Marley Medical rides the growing trend of virtual healthcare and chronic disease management, which has gained momentum due to increasing chronic disease prevalence and patient demand for convenient care. The timing is favorable as telehealth adoption has accelerated post-pandemic, and payers are increasingly interested in risk-based care models that improve outcomes and reduce costs. Marley Medical’s focus on chronic conditions addresses a critical healthcare challenge—long-term disease management—while leveraging technology to enhance patient engagement and adherence. Its model influences the broader ecosystem by demonstrating how virtual primary care can be specialized, insurance-integrated, and patient-centric, potentially setting a new standard for chronic care delivery[1][4].
Looking ahead, Marley Medical is poised to expand its patient base and deepen payer partnerships, moving further into risk-based contracts that align incentives for better health outcomes. Trends such as increased remote monitoring, personalized medicine, and value-based care will shape its growth trajectory. As chronic disease management becomes a priority for healthcare systems and insurers, Marley Medical’s specialized virtual care model could become a preferred solution for patients and payers alike. Its influence may grow by demonstrating scalable, effective chronic care that reduces healthcare costs and improves quality of life, reinforcing its role as a leader in virtual primary care focused on chronic disease[1][4].